Atellica IM Diagnostic Test Kit Recalled for Calibration Interval Deficiency
Siemens Healthcare recalls the Atellica IM BR 27.29 diagnostic test kit because it does not maintain the claimed 10-day calibration interval; the required interval has been shortened to 3 days to ensure accurate results.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This is a Class II in vitro diagnostic device where the product does not maintain the claimed calibration interval, creating risk of inaccurate test results. Although no illnesses or injuries have been reported, diagnostic inaccuracy poses a risk of harm through incorrect patient management decisions.
Plain-English summary
The Atellica IM BR 27.29 (BR) Assay 50 Test Kit is an in vitro diagnostic device manufactured by Siemens Healthcare Diagnostics that measures cancer antigen CA 27.29 in blood serum and plasma. It is used in clinical laboratories to support cancer monitoring.
The manufacturer discovered that the kit does not maintain calibration for the full 10-day interval claimed in the Instructions for Use. To ensure accurate test results, the calibration interval has been shortened from 10 days to 3 days for all current and future kit lots.
The recall affects 580 units distributed worldwide, including the United States, Australia, Bahamas, India, Mexico, Saudi Arabia, and Vietnam. Affected lot numbers include 40476255 and 64505255 (expiring August 3, 2021), and 89332257 and 05694257 (expiring November 10, 2021).
Laboratories using affected kits should immediately follow the updated instructions requiring calibration every 3 days instead of every 10 days, as provided in the revised Instructions for Use from Siemens Healthcare Diagnostics.
The recalled product
- Product
- Atellica IM BR 27.29 (BR) Assay 50 Test Kit- in vitro diagnostic use in the quantitative serial determination of cancer antigen CA 27.29 in human serum and plasma (EDTA) using the Atellica IM Analyzer. SMN: 10995478
- Manufacturer
- Siemens Healthcare Diagnostics, Inc
- Affected units
- 580
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- Lot numbers: 89332257 & 05694257 expiration date 2021-11-10.
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 3 recalled by Siemens Healthcare Diagnostics, Inc under a single FDA (Devices) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 3 products in this recall →Related recalls
Same manufacturer · Siemens Healthcare Diagnostics, Inc
See all →- SevereSiemens Recalls Emit 2000 Quinidine Assay Due to Precision Issues
FDA (Devices) · 2026-08-26
- SevereSiemens Quinidine Assay Recalled for Precision Errors
FDA (Devices) · 2026-08-26
- HighSiemens Atellica CH Urine Albumin In Vitro Diagnostic Recall
FDA (Devices) · 2026-08-12
- ModerateSiemens Tricyclic Antidepressant Calibrator/Controls Recall Lot U2
FDA (Devices) · 2026-08-12
- LowSyva Emit Disopyramide Enzyme Immunoassay Calibrator Recalled for Sodium Azide Concentration
FDA (Devices) · 2026-08-12
Same hazard · calibration drift
See all →- HighLandauer microSTARii reader recalled for measurement inaccuracy
FDA (Devices) · 2024-01-03
- HighMedfusion Syringe Pump Sensor Calibration Drift May Cause False Alarms
FDA (Devices) · 2023-10-18
- HighMedfusion Syringe Pumps Recalled for Force Sensor Calibration Drift
FDA (Devices) · 2023-10-18
- HighMedfusion Syringe Pump Recalled for Occlusion Detection Calibration Drift
FDA (Devices) · 2023-10-18
- HighMedfusion Infusion Pump Plunger Sensor Calibration Drift Recall
FDA (Devices) · 2023-10-18